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Abstract
Publications on diagnosed HIV infection among transgender people have been limited to state- or 
local-level data. We analyzed data from the National HIV Surveillance System and present results 
from the first national-level analysis of transgender people with diagnosed HIV infection. From 
2009 to 2014, HIV surveillance jurisdictions from 45 states plus the District of Columbia 
identified and reported at least one case of newly diagnosed HIV infection for transgender people; 
jurisdictions from 5 states reported no cases for transgender people. Of 2351 transgender people 
with newly diagnosed HIV infection during 2009–2014, 84.0% were transgender women (male-to-
female), 15.4% were transgender men (female-to-male), and 0.7% were additional gender identity 
(e.g., gender queer, bi-gender). Over half of both transgender women (50.8%; 1002/1974) and men 
(58.4%; 211/361) with newly diagnosed HIV infection were non-Hispanic black/African 
American. Improvements in data collection methods and quality are needed to gain a better 
understanding of HIV burden among transgender people.
Resumen
Las publicaciones sobre el diagnóstico de la infección por VIH entre personas transgénero se han 
limitado a los datos estatales o locales. Analizamos los datos del Sistema Nacional de Vigilancia 
del VIH y presentamos los resultados del primer análisis a nivel nacional de personas transgénero 
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con diagnóstico de infección por VIH. Del 2009 al 2014, las jurisdicciones de vigilancia del VIH 
de 45 estados más el Distrito de Columbia identificaron y reportaron al menos un caso de 
infección de VIH recientemente diagnosticada en personas transgénero; Jurisdicciones de 5 
estados no reportaron casos en personas transgénero. De las 2.351 personas transgénero con 
infección por el VIH recién diagnosticada durante el perıodo 2009–2014, el 84,0% eran mujeres 
transgénero (hombre a mujer), el 15,4% hombres transgéneros (mujer a hombre) y el 0,7% (género 
queer, bi-género). Más de la mitad de las mujeres (50,8%; 1002/1974) y los hombres (58,4%; 
211/361) transgénero con infección por el VIH recientemente diagnosticada eran negros/
afroamericanos. Se necesitan mejoras en los métodos de recopilación de datos y en la calidad de 
los datos para comprender mejor la cantidad de VIH en la población transgénero.
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Introduction
“Transgender” is a comprehensive term for identifying people whose sex assigned at birth 
does not match their current gender identity or expression [1, 2]. In this study, we use 
“transgender woman” to describe someone who was reported as having a male sex assigned 
at birth and who currently identifies as a woman, male-to-female (MTF) transgender, 
transfeminine, or something similar; “transgender man” to describe someone who was 
reported as having a female sex assigned at birth and who currently identifies as a man, 
female-to-male (FTM) transgender, transmasculine, or something similar; “additional gender 
identity” to describe someone who was reported as having another documented gender 
identity (e.g., gender queer, bigender); and “cisgender” to describe persons with congruence 
between their sex assigned birth and current gender identity (Table 1) [1, 2]. The National 
HIV/AIDS Strategy includes transgender populations among those in need of HIV 
prevention efforts and programs [3]. However, knowledge of actual HIV burden among 
transgender people in the United States is limited.
In the United States, transgender persons may be disproportionately affected by HIV 
infection. Among transgender women, the estimated (pooled) HIV prevalence of 21.7% 
(95% confidence interval 18.4–25.1) is 34 times as high as among other reproductive-age 
cisgender adults (15–49 years) [4]. In addition, the Centers for Disease Control and 
Prevention (CDC) reported that during 2013, transgender people had the highest percentage 
of newly confirmed HIV-positive testing events (1.9% of all HIV testing events), compared 
to cisgender males (0.9%) and cisgender females (0.2%) [5].
Reports involving state and city-level HIV surveillance data show that transgender people 
typically comprise about 1% (range 0.2–2%) of all newly diagnosed HIV infections, AIDS 
diagnoses, or people living with diagnosed HIV infection [6–16]. However, this percentage 
is likely to be an underestimate of the true number of transgender people with newly or 
previously diagnosed HIV in these jurisdictions. Two jurisdictions (Los Angeles County and 
New York City) have estimated that the number of newly diagnosed cases that they 
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classified as being among transgender people represented approximately half of the actual 
number of new diagnoses for this population [17, 18]. In 4 of 5 reports from jurisdictions 
that stratified HIV data by gender identity, 91–100% of transgender people with newly 
diagnosed or prevalent HIV infection were transgender women [11–14, 16].
Researchers have found racial/ethnic disparities in HIV infection among transgender people, 
with higher percentages for confirmed or self-reported HIV infection among black/African 
American transgender women compared to transgender women from other racial/ethnic 
groups. A meta-analysis by Herbst, et al. found that black/African American transgender 
women have a higher percentage of confirmed HIV infection (56.3%) compared to whites 
(16.7%) or Hispanics or Latinos (16.1%) [19]. Using national HIV testing data from 2009 to 
2011 collected by CDC-funded sites, Habarta, et al. found black/African American (adjusted 
odds ratio [AOR] 4.6 compared to white) or Hispanic or Latino (AOR 2.6) race/ethnicity to 
be associated with positive HIV test results for transgender women [20]. Other researchers 
have found racial/ethnic disparities for confirmed or self-reported HIV infection among 
large samples of transgender women from metropolitan areas [13, 21, 22].
Using qualitative and quantitative methods, researchers have identified several types of HIV-
related risk behaviors among transgender people, including multiple sexual partners, 
unprotected receptive anal or vaginal sex, injecting hormones or drugs and/or sharing 
syringes and other drug paraphernalia, and commercial sex work [22–38]. Transgender 
people also experience factors related to stigma and marginalization that may increase their 
vulnerability to HIV infection, including discrimination and/or victimization, homelessness, 
incarceration, lack of healthcare insurance or healthcare access, mental health issues, 
suicidal ideation or attempts, and unemployment/underemployment [30, 39–46]. Although 
HIV-related risk behaviors and other mediating factors have been well documented in the 
literature, most of these studies have involved convenience samples from venues or smaller 
geographic regions.
A lack of nationally representative data sources for transgender populations has prompted 
professional, academic, and federal agencies or organizations to call for improved data 
collection efforts [47–53]. The United States Department of Health and Human Services 
(HHS) has committed to increasing the number of federally funded health and demographic 
surveys that collect and report sexual orientation and gender identity data and has added an 
objective to Healthy People 2020 aimed at transgender-specific data collection [54–56]. One 
approach for collecting information on transgender persons is a two-step model, which 
involves collecting both sex assigned at birth and current gender identify. The two-step 
model shows high comprehension among transgender survey respondents and compared to a 
one-question approach, has been shown to result in fewer missing responses and more 
accurate information [2, 52, 53]. This approach has been used by several national or multi-
state data systems, including the CDC’s National HIV Surveillance System (NHSS) [5, 57–
59].
This study is the first to use NHSS data to examine diagnosed HIV infection among 
transgender people in the United States and describe socio-demographic and HIV-related 
characteristics of transgender people newly diagnosed with HIV infection. National-level 
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data on the number and characteristics of transgender people with newly diagnosed HIV 
infection can inform and guide HIV prevention and treatment efforts for transgender persons 
in the United States.
Methods
The CDC funds 57 jurisdictions in the United States, including 50 states, the District of 
Columbia and 6 dependent areas, to collect information on diagnosed HIV infection [60]. 
Jurisdictions apply document-based surveillance methods and collect information on persons 
with newly and previously diagnosed HIV infection from various document types, including 
case reports, laboratory reports, death certificates, birth certificates, and other documents. 
Jurisdictions report these data void of personally identifying information to the NHSS using 
a secure data system (the Enhanced HIV/AIDS Reporting System, or eHARS). By 2009, 
jurisdictions had the option to submit information on current gender identity to CDC using 
eHARS. During 2011, the fields used to collect information on transgender status were 
revised, updated in eHARS, and added to the HIV case report form for adults and 
adolescents (see Current gender identity, defined below). Of the 51 jurisdictions that we 
evaluated, 46 had identified and reported at least one transgender adult or adolescent with 
newly diagnosed HIV infection during 2009–2014.
We examined data on newly diagnosed HIV infection from 2009 through 2014 that 
jurisdictions had reported by June 30, 2016, excluding data from the 6 United States 
dependent areas. For adult and adolescent transgender people (≥13 years at the time of 
diagnosis) with newly diagnosed HIV infection during 2009 to 2014, we examined socio-
demographic and HIV-related characteristics and calculated HIV case counts and 
percentages by each characteristic (Table 2).
Sex Assigned at Birth
Personnel from jurisdictions collect information on sex assigned at birth from documents 
such as birth certificates, laboratory reports, medical records, and death certificates. For the 
NHSS, a hierarchy is applied to select the document with the value that is most likely to 
accurately represent a person’s sex assigned at birth (e.g., birth certificate has highest 
priority).
Current Gender Identity
Personnel from jurisdictions that collect information on gender identity use data sources 
such as HIV case report forms submitted by healthcare or HIV testing providers, medical 
records, or matches with other health department databases (e.g., Ryan White program data). 
We used information that was collected on HIV case report forms for adults and adolescents 
with diagnosed HIV infection, excluding data from laboratory reports and other document 
types. Laboratory personnel generally do not interact with patients and therefore may not 
have the opportunity to verify an individual’s current gender identity. Further, current gender 
identity is rarely included in other document types (e.g., birth certificates, death certificates). 
After removing documents with errors (e.g., documents with a value of “female” for sex 
assigned at birth and “transgender–MTF” for current gender identity), we examined current 
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gender identity data that were reported to the NHSS on HIV case report forms. Persons with 
at least one HIV case report form containing a value for current gender identity that differed 
from the person’s sex assigned at birth were considered to be transgender. We used the 
algorithm presented in Table 1 to assign transgender status and transmission category 
(described below).
Diagnoses of HIV Infection
We applied the 2008 revised HIV surveillance case definition, assigning a stage of 1, 2, 3 
(AIDS), or unknown to cases based on laboratory evidence [61]. To assign transmission 
categories for people with diagnosed HIV infection, the CDC uses a hierarchical algorithm 
that incorporates individual HIV risk factors and assigned sex at birth [62, 63]. Therefore, a 
transgender woman who had sexual contact with an HIV-infected cisgender male is typically 
assigned a transmission category of male-to-male sexual contact (MSM). However, for this 
analysis, we combined the transmission categories of MSM and heterosexual contact into 
the common category “sexual contact”, and MSM/injection drug use (IDU) into the common 
category “sexual contact/IDU.” We maintained the original categories of “IDU” for people 
with diagnosed HIV infection attributable to injection drug use, “other” for people with 
diagnosed HIV infection attributable to hemophilia, blood transfusion, or other rare modes 
of transmission, and “no identified or reported risk (NIR)” for people with an unknown 
transmission category. For facilities where transgender people were initially diagnosed with 
HIV infection, we used the NHSS categories of inpatient, outpatient, emergency room, 
screening, diagnostic, or referral site, laboratory, and other/unknown. Screening, diagnostic, 
or referral sites include facilities that provide HIV counseling and testing services but not 
ongoing healthcare (e.g., blood bank, drug treatment center, family planning clinic, HIV 
counseling and testing site, etc.).
Other Socio-demographic Characteristics
To collect information on race/ethnicity, the NHSS applies the Office of Management and 
Budget guidelines from 1997, which allow the identification of one or more race categories 
along with Hispanic or Latino ethnicity [62, 64]. We presented both age group and United 
States region of residence as of the time of diagnosis of HIV infection. Jurisdictions’ 
methods for collecting information on country of birth have been described elsewhere [63]. 
For vital status, we used information on deaths that jurisdictions reported to the NHSS by 
June 30, 2016.
Results
Jurisdictions identified and reported 2351 transgender people with newly diagnosed HIV 
infection during 2009 to 2014, of whom 84.0% were transgender women, 15.4% were 
transgender men, and 0.7% had an additional gender identity (Table 2; data not shown for 
persons with an additional gender identity). Among 50 states and the District of Columbia, 
46 had at least one new diagnosis of HIV for a transgender person during 2009–2014. The 
highest numbers of new diagnoses during 2009–2014 were reported from California, 
followed by New York, Georgia, and Texas. The annual number of cases did not vary 
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significantly during the 5 years. Due to small cell sizes, we did not present annual data for 
transgender people by state or those with an additional gender identity.
Transgender Women
Of the 1974 transgender women with newly diagnosed HIV infection during 2009–2014, 
half (50.8%) were non-Hispanic black/African American, 29.3% Hispanic or Latino, 10.7% 
non-Hispanic white, 6.1% multiple races, 1.9% Asian, 0.7% American Indian/Alaska 
Native, and 0.6% Native Hawaiian/other Pacific Islander (Table 2). Most transgender women 
were diagnosed with HIV infection at age 34 or younger: 8.3% at ages 13–19, 28.0% at ages 
20–24, and 36.3% at ages 25–34. The largest proportion of cases (42.8%) resided in the 
South (includes Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, 
Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, 
Tennessee, Texas, Virginia, and West Virginia) at the time of diagnosis and most (69.1%) 
were born in the United States. Most transgender women (86.8%) were diagnosed with HIV 
attributable to sexual contact, and 17.4% were diagnosed with HIV infection, stage 3 (AIDS) 
within 3 months of their HIV diagnosis. Close to half (41.9%) of transgender women were 
diagnosed in outpatient settings, 22.5% in HIV screening, testing, or referral sites, and 
12.4% in inpatient settings. Diagnoses were approximately equally distributed by year of 
diagnosis. Less than 5% (4.2%) of transgender women were known to be deceased.
Transgender Men
Similar to transgender women, over half (58.4%) of the 361 transgender men with newly 
diagnosed HIV infection were non-Hispanic black/African American; 15.2% were Hispanic 
or Latino, 15.5% non-Hispanic white, 8.6% multiple races, 1.4% Asian, and 0.8% American 
Indian/Alaska Native (Table 2). Over half (53.5%) of transgender men were newly 
diagnosed with HIV at age 34 or younger (6.4% were 13–19, 16.6% were 20–24, and 30.5% 
were 25–34) and over half (53.5%) resided in the South at the time of diagnosis. 
Approximately two-thirds (69.3%) were born in the United States. Over half (56.8%) had an 
unknown transmission category; 34.1% were diagnosed with HIV attributable to sexual 
contact, and 8.9% were diagnosed with HIV attributable to IDU. Nearly one-quarter (22.4%) 
were diagnosed with HIV infection, stage 3 (AIDS) within 3 months of their HIV diagnosis. 
Four-tenths (41.8%) were diagnosed in outpatient settings. Diagnoses for transgender men 
were approximately equally distributed by year. Less than 10% (6.4%) of transgender men 
were known to be deceased.
Discussion
Our analysis is the first to use national surveillance data to explore HIV diagnosis among 
transgender people. Among transgender people with newly diagnosed HIV during 2009–
2014 with data reported to the NHSS, over three-quarters were transgender women. This 
finding is consistent with research involving data from HIV prevention and testing programs, 
behavioral interventions, and surveys that show high percentages of transgender women with 
self-reported or diagnosed HIV infection [24, 19]. Comparable literature on HIV infection 
among transgender men is scarce [65]. We identified 361 transgender men with newly 
diagnosed HIV during 2009–2014. Our results may be among the first to be reported in the 
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literature that include a large number of transgender men with diagnosed HIV infection in 
the United States.
Similar to Herbst, et al., we found disparities among transgender adults and adolescents with 
newly diagnosed HIV [19]. Over half of both transgender women and men with newly 
diagnosed HIV infection during 2009–2014 were black/African American. In their meta-
analysis of studies on HIV among transgender populations, Herbst, et al. found the 
percentage of black/African American transgender women with confirmed HIV infection to 
be 3 times as high as the percentages for whites or Hispanics or Latinos [19]. We also found 
that close to half of both transgender women and transgender men resided in the South at the 
time of their HIV diagnosis. Other reports involving national HIV surveillance data have 
shown a higher HIV burden for the South, especially among blacks/African Americans [62, 
66, 67]. Among 45 states and the District of Columbia, Georgia and Texas had the third and 
fourth highest numbers (respectively) of transgender people with newly diagnosed HIV 
infection during 2009–2014. A combination of factors—including HIV prevalence and the 
maturity and quality of a jurisdiction’s transgender-specific data collection methods—may 
contribute to these results. Georgia began collecting transgender-specific data during 2008. 
During recent years, Texas has attempted to improve transgender-specific data collection. 
California (including the jurisdictions of Los Angeles County and San Francisco) and New 
York (including the jurisdiction of New York City) where data collection methods have been 
in place longer than many other states, had the first and second highest percentages 
(respectively) of newly diagnosed HIV cases for transgender people among the 45 states and 
the District of Columbia.
To assign transmission categories to cases of newly diagnosed HIV infection, we used an 
alternate method and collapsed NHSS transmission categories into broader ones. Had we 
used the standard categories, 86.0% of transgender women would have been described as 
having HIV attributable to male-to-male sexual contact and 7.5% as having HIV attributable 
to male-to-male sexual contact and injecting drugs; 34.1% of transgender men would have 
been described as having HIV attributable to heterosexual contact (i.e., sex with a man 
previously diagnosed with or at high risk for HIV). For transgender men, we found that over 
half had no identified or reported risk (compared to 4.9% for transgender women). 
Researchers have identified factors such as sex, age, birth country, facility type at diagnosis, 
race/ethnicity, region of residence, and vital status as contributing to higher NIR percentages 
[63]. To identify potential reasons for the discrepancy in NIR percentages between 
transgender men and transgender women, we would need to perform additional analyses to 
examine such factors and further evaluate jurisdictions’ methods for collecting and reporting 
HIV risk factor and transmission category data for transgender men.
One of the goals of both the National HIV/AIDS Strategy and Healthy People 2020 is to 
reduce the proportion of persons with a diagnosis of HIV infection, stage 3 (AIDS) within 3 
months of diagnosis of HIV [3, 56]. We found that for both transgender women and men, 
less than one-quarter were classified as stage 3 (AIDS) within 3 months of diagnosis. Using 
NHSS data from the same time period, the CDC found that approximately one-quarter of 
annual infections overall were classified as stage 3 at the time of diagnosis [68]. Although 
data from the CDC report are based on sex assigned at birth and therefore include 
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transgender people among the percentages for men and women, these percentages would not 
be greatly impacted by the exclusion of transgender people given their comparatively small 
number of diagnoses.
Our analysis is subject to the following limitations. These data may not represent the entire 
population of transgender people in the United States with newly diagnosed HIV during 
2009–2014. Instead, they are limited to cases of newly diagnosed HIV that jurisdictions 
identified and reported to the NHSS and that could be classified as transgender using an 
algorithm (Table 1). Diagnosed HIV among transgender populations may be vastly 
underreported or misclassified due to data collection challenges for jurisdictions, including 
correctly identifying current gender identity from documentation in medical records and 
other data sources [16, 17, 69–71]. Also, some transgender people may not identify as 
transgender in healthcare settings due to fear of discrimination or because of previous 
negative experiences [41]. Errors during documentation on HIV case report forms or data 
entry could lead to misclassification of transgender status in NHSS data, which could 
increase or decrease the number of persons apparently transgender (compared to cisgender) 
or transgender man (compared to transgender woman). Our exclusion of data from 
laboratory reports may have affected our estimate of the number of transgender people with 
newly diagnosed HIV infection. Information on current gender identity has not been 
consistently captured in electronic or paper laboratory reports. Whether to include data from 
laboratory reports and other documents when classifying transgender status should be 
reassessed when data collection methods and data quality have improved for these sources.
We applied an algorithm that classified as transgender anyone with at least one HIV case 
report that included a value of current gender identity that differed from sex assigned at 
birth. Our algorithm incorporates feedback from jurisdiction-level personnel, who suggested 
that once a person is classified as transgender, the person should maintain this classification 
in surveillance data regardless of current gender identity values from subsequent reports. A 
person’s gender identity and expression is fluid and may vary over time. However, the 
likelihood of someone identifying as transgender followed by cisgender seems more likely 
to be associated with errors in data collection or data entry, and/or by non-ascertainment of 
transgender identity at a given provider or facility, than with an actual change from 
transgender to cisgender identity. The methods used to classify transgender status among 
persons with diagnosed HIV infection should continue to be evaluated and improved.
As previously mentioned, jurisdictions with transgender-specific data collection methods in 
place for longer time periods may have more accurate data. Socio-demographic 
characteristics may be different for transgender people with newly diagnosed HIV who 
reside in states other than those we included in our analysis. Also, we excluded data for 
people with an additional gender identity, who comprised <1% of the study population and 
had small cell sizes.
Despite the limitations, our findings have several important implications for HIV prevention 
and care efforts and surveillance activities. First, we performed the first analysis of national 
surveillance data for transgender people with newly diagnosed HIV infection, providing 
results that can be used to supplement other analyses on HIV-related risk behaviors and/or 
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transmission categories for transgender people [5, 20, 57, 67, 72]. Second, racial and 
regional disparities are evident. Those who develop or implement HIV prevention and care 
programs should consider these disparities and tailor programs to the needs of transgender 
people. Third, HIV surveillance programs that do not currently have practices in place for 
collecting transgender-specific data should develop and implement such practices and 
continue to evaluate and improve upon them. Fourth, developing practices for capturing 
information from electronic and paper laboratory reports is essential to gaining a more 
complete picture of diagnosed HIV infection among transgender adults and adolescents. 
Finally, as national transgender population estimates become available, calculating HIV 
disease burden (e.g., HIV prevalence and diagnosis rates) among transgender people will 
become a reachable goal. Adequate population estimates have been published [73]. 
However, standard population estimates from the United States Census Bureau are 
unavailable, and further improvements to the quality of HIV surveillance data at the national 
and jurisdiction levels are needed [74].
In summary, our results showed a higher percentage of newly diagnosed HIV infection 
among transgender women than transgender men. Racial and regional disparities are evident. 
Improvements to data collection methods and data quality are needed. National and local 
agencies and providers serving transgender populations should tailor HIV prevention and 
treatment programs to be accepting of a person’s stated gender identity and be sensitive to 
the unique healthcare needs of transgender people living with HIV.
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Table 1
Algorithm for assigning transgender status to persons newly diagnosed with HIV
Assigned sex at birth Current gender identitya Transgender statusb
Male Missing or male Cisgender male
Male Female Transgender woman
Male Transgender – MTF Transgender woman
Male Additional gender identity Additional gender identity
Female Missing or female Cisgender female
Female Male Transgender man
Female Transgender – FTM Transgender man
Female Additional gender identity Additional gender identity
a
MTF = male-to-female. FTM = female-to-male. Additional gender identity = other documented, yet unspecified gender identities (e.g., gender 
queer).
b
Persons with any Adult Case Report Form document indicating a transgender woman, transgender man, or additional gender identity were 
included in the analysis. Adult Case Report Form documents with conflicting values for assigned sex at birth and current gender identity (e.g., 
assigned sex at birth = male, current gender identity = Transgender − FTM) were excluded.
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